Bellalgin is a combination drug that has analgesic, antispasmodic and antacid action.
Release form and composition
Available in the form of tablets containing:
- 250 mg of metamizole sodium;
- 250 mg of benzocaine;
- 100 mg of sodium bicarbonate;
- 15 mg of sodium bicarbonate.
Implemented tablets of 10 pcs. in blisters or jars packed in cartons.
Indications for use
According to the information given in the instructions for Bellalgin, this drug is intended for the symptomatic treatment of pain syndrome caused by gastrointestinal diseases, which are accompanied by spasms of smooth muscles and increased secretion of gastric juice. In particular, Bellalgin prescribed for:
- Hyperacid gastritis;
- Peptic ulcer and 12 duodenal ulcer;
- Spastic colitis;
According to the instructions to Bellalgin, the use of this drug is contraindicated in:
- Angle-closure glaucoma;
- Severe hepatic / renal failure;
- Prostatic hyperplasia;
- Aspirin Asthma;
- Inhibition of hematopoiesis (agranulocytosis, leukopenia, granulocytopenia, infectious or cytostatic neutropenia);
- Hereditary hemolytic anemia associated with deficiency of glucose-6-phosphate dehydrogenase;
- Pregnancy, especially in the first three and last 1.5 months;
With extreme caution Bellalgin prescribed:
- People who abuse alcohol;
- Patients with kidney disease (glomerulonephritis, pyelonephritis, etc., including a history of);
- Patients with atopic asthma and pollinosis;
- Simultaneously with cytostatics.
Dosing and Administration
Bellalgin tablets should be taken on 1 pc. before meals two or three times a day. The maximum allowable dose for adults: single - 3 tablets, daily - 10 tab.
The duration of treatment is determined individually for each patient, depending on the indication and intensity of the severity of the pain syndrome.
According to reviews of patients undergoing treatment with Bellalgin, this drug is generally well tolerated and has extremely rare side effects.
So, Bellalgin can cause the development of such adverse events on the part of body systems:
- Decrease in blood pressure, heart palpitations;
- Drowsiness, dizziness, psychomotor agitation, convulsions;
- Paresis of accommodation, mydriasis, temporary visual impairment;
- Dry mouth, thirst, constipation;
- Oliguria, urination disorders, proteinuria, anuria, urine staining in red, interstitial nephritis, renal dysfunction;
- Urticaria (including on the mucous membrane of the nasopharynx and conjunctiva), angioedema, in rare cases - anaphylactic shock, bronchospastic syndrome, toxic epidermal necrolysis;
- Thrombocytopenia, agranulocytosis and leukopenia.
When taking the drug in too high doses (significantly higher than those recommended by the instructions) may develop overdose symptoms such as gastralgia, nausea, vomiting, lowering blood pressure, hypothermia, oliguria, tachycardia, tinnitus, drowsiness, acute agranulocytosis, shortness of breath, delirium, acute hepatic / renal failure, impaired consciousness, convulsions, hemorrhagic syndrome, paralysis of the respiratory muscles. If any of the above symptoms appear, you should do a gastric lavage, take a saline laxative and activated carbon, call a doctor. In some cases, hemodialysis, forced diuresis may be required, and with the development of convulsive syndrome, intravenous administration of fast-acting barbiturates and Diazepam.
Bellalgin is not recommended for people whose activity is related to the performance of potentially hazardous types of work that require concentration of attention, visual acuity and / or speed of psychomotor reactions.
Until the exact causes are established, the drug should not be taken to relieve acute abdominal pain.
With the simultaneous use of Bellalgin with chlorpromazine or other phenothiazine derivatives, severe hyperthermia may develop.
Metamizole, which is part of the drug, can cause the development of agranulocytosis. For this reason, when the temperature rises, a sore throat, difficulty swallowing, chills, stomatitis, as well as the development of proctitis or vaginitis, you should immediately stop taking Bellalgin.
Metamizol is pharmaceutically incompatible with colloidal blood substitutes, penicillin, X-ray contrast agents.
If necessary, long-term use of Bellalgin requires control of the pattern of peripheral blood.
During treatment with this drug is not recommended to drink alcohol.
Metamizole enhances the effect of indirect anticoagulants, indomethacin, oral hypoglycemic and glucocorticosteroid drugs. And its analgesic effect is enhanced by anxiolytic and sedative drugs, reduced - barbiturates and phenylbutazone.
Combined use of Bellalgin with allopurinol, tricyclic antidepressants, hormonal contraceptives and other non-narcotic analgesics can lead to increased toxicity.
With the simultaneous use of cytostatics or tiamazol increases the risk of leukopenia.
Bellalgin reduces the concentration of cyclosporine in the blood.
There are no structural analogues for Bellalgin. With a similar mechanism of action, Spasmil-M and Bellastezin are released.
Terms and conditions of storage
Bellalgin is a drug approved for dispensing from pharmacies as a non-prescription drug. Keep it in a cool dry place, protected from direct sunlight. Under these conditions, the shelf life of tablets is 3 years.